Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG)
Authors:
- Eu Jeen YangEYEu Jeen Yang
- Ye Jee ShimYSYe Jee Shim
- Heung Sik KimHKHeung Sik Kim
- Young Tak LimYLYoung Tak Lim
- Ho Joon ImHIHo Joon Im
- Kyung-Nam KohKKKyung-Nam Koh
- Hyery KimHKHyery Kim
- Jin Kyung SuhJSJin Kyung Suh
- Eun Sil ParkEPEun Sil Park
- Na Hee LeeNLNa Hee Lee
- Young Bae ChoiYCYoung Bae Choi
- Jeong Ok HahJHJeong Ok Hah
Open Access
Abstract
The diagnosis of inherited platelet function disorders (IPFDs) is challenging owing to the unavailability of essential testing methods, including light transmission aggregometry and flow cytometry, in several medical centers in Korea. This study, conducted by the Korean Pediatric Hematology Oncology Group from March 2017 to December 2020, aimed to identify the causative genetic variants of IPFDs in Korean patients using next-generation sequencing (NGS). Targeted exome sequencing, followed by whole-genome sequencing, was performed for diagnosing IPFDs. Of the 11 unrelated patients with suspected IPFDs enrolled in this study, 10 patients and 2 of their family members were diagnosed with Glanzmann thrombasthenia (GT). The variant c.1913+5G>T of ITGB3 was the most common, followed by c.2333A>C (p.Gln778Pro) of ITGB2B. Known variants of GT, including c.917A>C (p.His306Pro) of ITGB3 and c.2975del (p.Glu992Glyfs*), c.257T>C (p.Leu86Pro), and c.1750C>T (p.Arg584*) of ITGA2B, were identified. Four novel variants of GT, c.1451G>T (p.Gly484Val) and c.1595G>T (p.Cys532Phe) of ITGB3 and c.1184G>T (p.Gly395Val) and c.2390del (p.Gly797Valfs*29) of ITGA2B, were revealed. The remaining patient was diagnosed with platelet type bleeding disorder 18 and harbored two novel RASGRP2 variants, c.1479dup (p.Arg494Alafs*54) and c.813+1G>A. We demonstrated the successful application of NGS for the accurate and differential diagnosis of heterogeneous IPFDs.Keywords
Funding Information
- This research was supported by a Bisa Research Grant from the Keimyung University in 2019. (2019)
This publication has 23 references indexed in Scilit:
- Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutationsThrombosis and Haemostasis, 2015
- Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2014
- Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleedingJournal of Experimental Medicine, 2014
- Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombastheniaPediatric Blood & Cancer, 2011
- Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse modelsBlood, 2011
- Double heterozygosity for a novel missense mutation of Ile304 to Asn in addition to the missense mutation His280 to Pro in the integrin β3gene as a cause of the absence of platelet αIIbβ3in Glanzmann's thrombastheniaJournal of Thrombosis and Haemostasis, 2004
- A Leu55 to Pro substitution in the integrin αIIb is responsible for a case of Glanzmann's thrombastheniaBritish Journal of Haematology, 2002
- Two New β3 Integrin Mutations in Indian Patients with Glanzmann Thrombasthenia: Localization of Mutations Affecting Cysteine Residues in Integrin β3Thrombosis and Haemostasis, 2002
- Three Novel Integrin β3 Subunit Missense Mutations (H280P, C560F, and G579S) in Thrombasthenia, Including One (H280P) Prevalent in Japanese PatientsBiochemical and Biophysical Research Communications, 1998
- Novel point mutations in the αIIb subunit (Phe289 → Ser, Glu324 → Lys and Gln747 → Pro) causing thrombasthenic phenotypes in four Japanese patientsBritish Journal of Haematology, 1998